Gracell Biotechnologies
(NASDAQ) GRCL
Gracell Biotechnologies Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$0.00
Net Income (TTM)
$496.98M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
GRCL News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Gracell Biotechnologies
Industry
Biotechnology
Sector
Health CareEmployees
314
CEO
Wei Cao, PhD
Website
www.gracellbio.comHeadquarters
Suzhou, 215123, CN
GRCL Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-38%
Return on Capital
-44%
Return on Assets
-37%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$0.00
Operating Income
$624.66M
EBITDA
$568.67M
Operating Cash Flow
$3.31B
Capital Expenditure
$331.55M
Free Cash Flow
$3.64B
Cash & ST Invst.
$1.46B
Total Debt
$182.98M
Gracell Biotechnologies Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
314
N/A
Net Income
$67.63M
+60.7%
EBITDA
$109.45M
+33.3%
Quarterly Fundamentals
Net Cash
$1.59B
+11.7%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$35.37M
-37.9%
Short Term Debt
$80.45M
-45.2%
Return on Assets
-36.68%
N/A
Return on Invested Capital
-43.51%
N/A
Free Cash Flow
$0.00
N/A
Operating Cash Flow
$0.00
N/A